1-4 of 4
Mindy Pomtree
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

NY-ESO-1 is highly expressed in poor-prognosis multiple myeloma and induces spontaneous humoral and cellular immune responses

Clinical Trials & Observations
Frits van Rhee, Susann M. Szmania, Fenghuang Zhan, Sushil K. Gupta, Mindy Pomtree, Pei Lin, Ramesh B. Batchu, Amberly Moreno, Guilio Spagnoli, John Shaughnessy, Guido Tricot
Journal: Blood
Blood (2005) 105 (10): 3939–3944.
https://doi.org/10.1182/blood-2004-09-3707
Published: 2005
Journal Articles

NY-ESO-1 Specific T-Cells Are Spontaneously Present in High-Risk Myeloma and Kill Primary Myeloma Cells.

Frits van Rhee, MD, PhD, Susann M. Szmania, BS, Amberly Moreno, BS, Ramesh Batchu, PhD, Mindy Pomtree, BS, Nancy Rosen, Michele Cottler-Fox, MD, Bart Barlogie, MD, PhD, Guido J. Trico, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 2454.
https://doi.org/10.1182/blood.V104.11.2454.2454
Published: 2004
Journal Articles

NY-ESO-1 Specific Antibodies Are Frequently Detected in Hight-Risk Myeloma.

Frits van Rhee, MD, PhD, Susann M. Szmania, BS, Mindy Pomtree, Frank Zhan, Amberly Moreno, BS, Nancy Rosen, Michele Fox, MD, Bart Barlogie, MD, PhD, John Shaughnessy, PhD, Ramesh Batchu, PhD, Guido J. Tricot, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 2464.
https://doi.org/10.1182/blood.V104.11.2464.2464
Published: 2004
Journal Articles

A Novel Strategy for Combining Immunotherapy with High Dose Chemotherapy and Auto-Transplantation in High Risk Multiple Myeloma.

Susann Szmania, BS, Michele Cottler-Fox, MD, Nancy Rosen, BS, Sanjaya Viswamitra, MD, Amberly Moreno, BS, Mindy Pomtree, BS, Bart Barlogie, MD, PhD, Guido Tricot, MD, PhD, Frits van Rhee, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 2920.
https://doi.org/10.1182/blood.V104.11.2920.2920
Published: 2004